Table 2.
Chr | Gene | Pos first SNP | Pos last SNP | V0.05 | S_MAF | β | P | βa | Pa |
---|---|---|---|---|---|---|---|---|---|
2 | SLC19A3 | 228,552,234 | 228,563,911 | 3 | 0.054 | −0.266 | 5.85E-06 | −0.166 | 2.77E-03 |
11 | MADD | 47,296,533 | 47,315,499 | 2 | 0.054 | −0.254 | 2.00E-05 | −0.169 | 2.85E-03 |
11 | C11orf82 | 82,625,814 | 82,644,904 | 4 | 0.080 | −0.208 | 3.08E-05 | −0.105 | 2.71E-02 |
11 | KDELC2 | 108,352,777 | 108,357,137 | 2 | 0.054 | −0.241 | 5.24E-05 | −0.219 | 5.21E-04 |
12 | LRRK2 | 40,619,082 | 40,758,652 | 4 | 0.054 | −0.223 | 2.84E-04 | −0.133 | 2.09E-02 |
14 | SLC8A3 | 70,527,576 | 70,634,200 | 3 | 0.071 | −0.196 | 2.56E-04 | −0.049 | 3.68E-01 |
14 | SLC24A4 | 92,909,807 | 92,959,940 | 5 | 0.063 | −0.177 | 5.30E-06 | −0.288 | 1.00E-04 |
15 | STARD9 | 42,930,972 | 43,011,009 | 8 | 0.080 | −0.109 | 3.11E-04 | −0.053 | 3.45E-01 |
19 | GRIN3B | 1,000,785 | 1,009,585 | 3 | 0.063 | −0.190 | 9.00E-05 | −0.119 | 3.47E-02 |
19 | LENG8 | 54,966,557 | 54,968,038 | 3 | 0.063 | −0.202 | 2.35E-04 | −0.112 | 3.52E-02 |
V0.05 = SNPs with MAF<0.05; S_MAF= Sum of the V0.05 minor allele frequencies; β= Effect size not adjusted for APOE; P= P-value not adjusted for APOE.
Analysis that adjusts for APOE. All analyses were based on N=56 subjects.